SAFISONT Trademark

Trademark Overview

On Thursday, May 24, 2007, a trademark application was filed for SAFISONT with the United States Patent and Trademark Office. The USPTO has given the SAFISONT trademark a serial number of 77190066. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 7, 2011. This trademark is owned by MedImmune, Inc.. The SAFISONT trademark is filed in the Pharmaceutical Products category with the following description:

Biochemical preparations for medical purposes, namely, humanized monoclonal antibody against respiratory syncytial virus for medical clinical use
safisont

General Information

Serial Number77190066
Word MarkSAFISONT
Filing DateThursday, May 24, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 7, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2007

Trademark Statements

Goods and ServicesBiochemical preparations for medical purposes, namely, humanized monoclonal antibody against respiratory syncytial virus for medical clinical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 1, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMEDIMMUNE, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressGAITHERSBURG, MD 20878
Party NameMedImmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameMedImmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, March 7, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 7, 2011ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 7, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 6, 2010EXTENSION 5 GRANTED
Tuesday, August 3, 2010EXTENSION 5 FILED
Tuesday, August 3, 2010TEAS EXTENSION RECEIVED
Monday, February 8, 2010EXTENSION 4 GRANTED
Thursday, February 4, 2010EXTENSION 4 FILED
Thursday, February 4, 2010TEAS EXTENSION RECEIVED
Thursday, July 2, 2009EXTENSION 3 GRANTED
Wednesday, July 1, 2009EXTENSION 3 FILED
Wednesday, July 1, 2009TEAS EXTENSION RECEIVED
Tuesday, January 13, 2009EXTENSION 2 GRANTED
Monday, January 12, 2009EXTENSION 2 FILED
Monday, January 12, 2009TEAS EXTENSION RECEIVED
Friday, August 15, 2008EXTENSION 1 GRANTED
Tuesday, August 5, 2008EXTENSION 1 FILED
Friday, August 15, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 6, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 5, 2008TEAS EXTENSION RECEIVED
Thursday, March 27, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 27, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 5, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2007NOTICE OF PUBLICATION
Thursday, October 11, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 11, 2007ASSIGNED TO LIE
Tuesday, September 11, 2007EXAMINER'S AMENDMENT MAILED
Tuesday, September 11, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 11, 2007EXAMINER'S AMENDMENT ENTERED
Tuesday, September 11, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 5, 2007ASSIGNED TO EXAMINER
Friday, June 1, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

safisont medical respiratory against syncytial virus clinical antibody monoclonal preparations purposes